Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 4 (2007), Issue 6 (June)

1. Hibernoma: 18F FDG PET/CT imaging.
   J Thorac Oncol, 2(6): 569-70. [Abstract] [Full-text]
2. Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells.
   Cancer Res, 67(11): 5397-407. [Abstract] [Full-text]
3. Distinctive features of angiogenesis and lymphangiogenesis determine their functionality during de novo tumor development.
   Cancer Res, 67(11): 5211-20. [Abstract] [Full-text]
4. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
   Histopathology, 50(7): 835-42. [Abstract] [Full-text]
5. Prognostic value of tumor thickness in patients with Merkel cell carcinoma.
   J Surg Oncol, 95(8): 618-22. [Abstract] [Full-text]
6. What is a sentinel node? Re-evaluating the 10% rule for sentinel lymph node biopsy in melanoma.
   J Surg Oncol, 95(8): 623-8. [Abstract] [Full-text]
7. Methylselenol generated from selenomethionine by methioninase downregulates integrin expression and induces caspase-mediated apoptosis of B16F10 melanoma cells.
   J Cell Physiol, 212(2): 386-400. [Abstract] [Full-text]
8. Oblimersen in the treatment of metastatic melanoma.
   Future Oncol, 3(3): 263-71. [Abstract] [Full-text]
9. A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma.
   Am J Clin Oncol, 30(3): 303-9. [Abstract] [Full-text]
10. A better technique for taking Mohs sections involving cartilage.
    Dermatol Surg, 33(6): 716-21. [Abstract] [Full-text]
11. Reconstruction of lower eyelid defects using a cross upper eyelid flap composited with ear cartilage.
    Dermatol Surg, 33(6): 709-12. [Abstract] [Full-text]
12. A pilot feasibility study of a rare skin tumor database.
    Dermatol Surg, 33(6): 693-6. [Abstract] [Full-text]
13. Effect of the physicochemical properties of poly(ethylene glycol) brushes on their binding to cells.
    Biophys J, 93(1): 324-34. [Abstract] [Full-text]
14. Dietary chromium and nickel enhance UV-carcinogenesis in skin of hairless mice.
    Toxicol Appl Pharmacol, 221(3): 329-38. [Abstract] [Full-text]
15. Surgical therapy of cutaneous melanoma.
    Semin Oncol, 34(3): 270-80. [Abstract] [Full-text]
16. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
    Surgery, 141(6): 728-35. [Abstract] [Full-text]
17. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.
    J Clin Pathol, 60(6): 596-9. [Abstract] [Full-text]
18. Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids.
    Virology, 364(2): 355-61. [Abstract] [Full-text]
19. Chemopreventive effects of sarcophine-diol on skin tumor development in CD-1 mice.
    Cancer Lett, 253(1): 53-9. [Abstract] [Full-text]
20. FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin.
    J Invest Dermatol, 127(7): 1572-3. [Abstract] [Full-text]
21. Absence of microsatellite instability and lack of evidence for subclone diversification in the pathogenesis and progression of mycosis fungoides.
    J Invest Dermatol, 127(7): 1752-61. [Abstract] [Full-text]
22. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy.
    J Invest Dermatol, 127(7): 1647-56. [Abstract] [Full-text]
23. Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions.
    J Invest Dermatol, 127(7): 1673-80. [Abstract] [Full-text]
24. Lubrol-RAFTs in melanoma cells: a molecular platform for tumor-promoting ephrin-B2-integrin-beta1 interaction.
    J Invest Dermatol, 127(7): 1615-21. [Abstract] [Full-text]
25. Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type.
    J Invest Dermatol, 127(7): 1745-51. [Abstract] [Full-text]
26. Convergence of congenic mapping and allele-specific alterations in tumors for the resolution of the Skts1 skin tumor susceptibility locus.
    Oncogene, 26(28): 4171-8. [Abstract] [Full-text]
27. Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors.
    J Invest Dermatol, 127(7): 1664-6. [Abstract] [Full-text]
28. T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.
    Genes Cells, 12(6): 787-96. [Abstract] [Full-text]
29. The periglabellar flap for closure of central forehead defects.
    Plast Reconstr Surg, 120(1): 130-3. [Abstract] [Full-text]
30. Post-radiotherapy vascular proliferations in mammary skin: a clinicopathologic study of 11 cases.
    J Am Acad Dermatol, 57(1): 126-33. [Abstract] [Full-text]
31. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005.
    J Am Acad Dermatol, 57(1): 60-6. [Abstract] [Full-text]
32. Diving into the blue: in vivo microscopic characterization of the dermoscopic blue hue.
    J Am Acad Dermatol, 57(1): 96-104. [Abstract] [Full-text]
33. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy.
    J Am Acad Dermatol, 57(1): 166-9. [Abstract] [Full-text]
34. Dermoscopy report: proposal for standardization. Results of a consensus meeting of the International Dermoscopy Society.
    J Am Acad Dermatol, 57(1): 84-95. [Abstract] [Full-text]
35. Clinical significance of the RT-PCR positive sentinel node in melanoma.
    J Surg Oncol, 95(7): 546-54. [Abstract] [Full-text]
36. Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.
    J Surg Res, 141(1): 72-7. [Abstract] [Full-text]
37. Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progression.
    Hum Pathol, 38(7): 995-1002. [Abstract] [Full-text]
38. Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia.
    Hum Pathol, 38(7): 1023-9. [Abstract] [Full-text]
39. Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.
    J Clin Oncol, 25(18): 2540-5. [Abstract] [Full-text]
40. Correlation of dermoscopy with in vivo reflectance confocal microscopy of streaks in melanocytic lesions.
    Arch Dermatol, 143(6): 727-34. [Abstract] [Full-text]
41. Deep penetrating nevus of cheek skin.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104(1): e49-52. [Abstract] [Full-text]
42. Umbilical metastasis from prostate carcinoma (Sister Mary Joseph's nodule): a case report and review of literature.
    J Cutan Pathol, 34(7): 581-3. [Abstract] [Full-text]
43. Differentiating spitzoid melanomas from Spitz nevi through CD99 expression.
    J Cutan Pathol, 34(7): 576-80. [Abstract] [Full-text]
44. Epithelioid fibrous papule - a new variant.
    J Cutan Pathol, 34(7): 571-5. [Abstract] [Full-text]
45. The many faces of blue nevus: a clinicopathologic study.
    J Cutan Pathol, 34(7): 543-51. [Abstract] [Full-text]
46. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR.
    J Cutan Pathol, 34(7): 535-42. [Abstract] [Full-text]
47. Histologic mimickers of mycosis fungoides: a review.
    J Cutan Pathol, 34(7): 519-25. [Abstract] [Full-text]
48. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
    Cancer Immunol Immunother, 56(9): 1459-69. [Abstract] [Full-text]
49. Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma.
    Cancer Immunol Immunother, 56(9): 1407-15. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.